GI
RLAY icon

GAMMA Investing’s Relay Therapeutics RLAY Stock Holding History

GAMMA Investing’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$51.4K Buy
2,850
+1,482
+108% +$28.4K ﹤0.01% 2349
2026
Q2 		$25.6K Buy
1,368
+202
+17% +$2.93K ﹤0.01% 2705
2026
Q1 		$11.6K Buy
1,166
+812
+229% +$7.26K ﹤0.01% 2996
2025
Q4 		$3K Buy
+354
New +$2.53K ﹤0.01% 3474
2024
Q4 		– Sell
-184
Closed -$1.3K – 3819
2024
Q3 		$1.3K Buy
184
+141
+328% +$1.05K ﹤0.01% 3189
2024
Q2 		$280 Sell
43
-138
-76% -$943 ﹤0.01% 3281
2024
Q1 		$1.5K Sell
181
-188
-51% -$1.83K ﹤0.01% 2841
2023
Q4 		$3.41K Buy
+369
New +$3.11K ﹤0.01% 2395

Other funds holding RLAY

CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

GAMMA Investing's RLAY Position: Q3 2026 in Review

GAMMA Investing increased its Relay Therapeutics (RLAY) stake by 108% in Q3 2026, buying an estimated $28.4K and bringing the position to 2,850 shares worth $51.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2349.

GAMMA Investing first reported a position in RLAY in Q4 2023 and has held it in 8 quarters since. 6 funds tracked by Wall St. Rank hold RLAY as of Q3 2026.

  • GAMMA Investing held 2,850 shares of Relay Therapeutics worth $51.4K as of Q3 2026.
  • GAMMA Investing bought 1,482 Relay Therapeutics shares in Q3 2026, an estimated $28.4K.
  • Relay Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2349 holding.
  • GAMMA Investing first reported a position in Relay Therapeutics in Q4 2023 and has held it in 8 quarters since.
  • 6 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.